STAT+: Newer GLP-1 drugs to combat obesity may be the next global battleground over access to medicines, expert warns
How obesity medications may become the next big battleground over access to medicines in lower-income countries.
How obesity medications may become the next big battleground over access to medicines in lower-income countries.